Next Article in Journal
The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma—Association with Clinical Outcome and Tumor Phenotypes
Next Article in Special Issue
A Triple Co-Delivery Liposomal Carrier That Enhances Apoptosis via an Intrinsic Pathway in Melanoma Cells
Previous Article in Journal
Do We Really Need Another Special Issue on NF-κB in Cancer and Inflammation?
Previous Article in Special Issue
Mangiferin-Loaded Polymeric Nanoparticles: Optical Characterization, Effect of Anti-topoisomerase I, and Cytotoxicity
Open AccessReview

Engineered Extracellular Vesicles as a Reliable Tool in Cancer Nanomedicine

Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
*
Author to whom correspondence should be addressed.
Equal contribution.
Cancers 2019, 11(12), 1979; https://doi.org/10.3390/cancers11121979
Received: 14 November 2019 / Revised: 3 December 2019 / Accepted: 4 December 2019 / Published: 9 December 2019
(This article belongs to the Special Issue Cancer Nanomedicine)
Fast diagnosis and more efficient therapies for cancer surely represent one of the huge tasks for the worldwide researchers’ and clinicians’ community. In the last two decades, our understanding of the biology and molecular pathology of cancer mechanisms, coupled with the continuous development of the material science and technological compounds, have successfully improved nanomedicine applications in oncology. This review argues on nanomedicine application of engineered extracellular vesicles (EVs) in oncology. All the most innovative processes of EVs engineering are discussed together with the related degree of applicability for each one of them in cancer nanomedicines. View Full-Text
Keywords: extracellular vesicles; exosomes; chemico-physical functionalization; loading; cancer; nanomedicine; translational medicine; nanotechnology: bioengineering extracellular vesicles; exosomes; chemico-physical functionalization; loading; cancer; nanomedicine; translational medicine; nanotechnology: bioengineering
Show Figures

Graphical abstract

MDPI and ACS Style

Susa, F.; Limongi, T.; Dumontel, B.; Vighetto, V.; Cauda, V. Engineered Extracellular Vesicles as a Reliable Tool in Cancer Nanomedicine. Cancers 2019, 11, 1979.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop